CLINICAL CHARACTERISTICS AND SURVIVAL RATES OF HEPATOCELLULAR CARCINOMA, A SYSTEMATIC REVIEW

Background: Hepatocellular carcinoma (HCC), which accounts for approximately 75% of primary liver tumors, is one of the most serious complications of chronic liver disease. It is now the sixth most common cancer in the world, contributing to the third leading cause of death from cancer.

Objectives: The study aims to summarize current evidences regarding clinical characteristics and survival rates of hepatocellular carcinoma

Methods: For article selection, the PubMed database were used. All relevant articles relevant with our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that was reviewed by the group members.

Conclusion: In conclusion, 13 were enrolled for final data extraction. The most common cause of HCC among Medicare patients is NAFLD which was linked to less HCC surveillance reception, early-stage identification, and somewhat worse survival when compared to other etiologies. Viremic HCC patients had lower survival than post-SVR patients and viremic patients who were treated and achieved SVR after HCC diagnosis.

Key words: liver, carcinoma, tumor, HCC, hepatocellular carcinom